Dow Up 0.25% Nasdaq Down 0.07%

RXi Pharmaceuticals Corporation (RXII)

-NasdaqCM
2.50 0.00(0.00%) 2:47PM EDT - Nasdaq Real Time Price
Prev Close:2.50
Open:2.51
Bid:2.49 x 800
Ask:2.50 x 200
1y Target Est:10.17
Beta:0.72
Next Earnings Date:N/A
Day's Range:2.47 - 2.55
52wk Range:2.21 - 6.84
Volume:80,452
Avg Vol (3m):151,262
Market Cap:35.07M
P/E (ttm):N/A
EPS (ttm):-1.33
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for RXII

Comparison

Symbol% ChgMkt Cap
RXII 0.00%35.07M
AGNUp 0.04%48.11B
ALNYDown 1.84%5.10B
MRNAUp 28.57%20.76M

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):93.51
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.80
Quarterly EPS Est (Sep-14) :-0.23
Mean Recommendation*:1.7
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

RXi Pharmaceuticals Corporation, a biotechnology company, focuses on discovering, developing, and commercializing therapies based on its proprietary, next-generation RNA interference (RNAi) platform. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback